Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-05-14Clinical Trial Update: Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating Paclitaxel, Cyclophosphamide, and Dexamethasone for relapsed or refractory multiple myeloma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating dinaciclib in combination with bortezomib and dexamethasone in relapsed plasma cell myeloma has completed.
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment
The update describes a method using an HA Score to identify patients with recurrent or refractory multiple myeloma who may benefit from hist…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: A Study of VLX1570 and Dexamethasone in Myeloma Patients [Phase 1, Phase 2]
A phase 1/2 study of VLX1570 in combination with dexamethasone for multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial update on safety and dosing for BT062 in patients with relapsed or refractory multiple myeloma; study completed with results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-05-04Clinical Trial Update: Modified Bortezomib-based Combination Therapy for Multiple Myeloma [Phase 4]
A Phase 4 clinical trial update on a modified bortezomib-based combination therapy for multiple myeloma, with current status not disclosed.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy [NA]
Clinical trial evaluating the efficacy of an intraoperative gamma camera with lymphoscintigraphy to identify sentinel lymph nodes in breast …
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Phase 1, Phase 2]
A phase 1/2 trial of Clofarabine combined with non-myeloablative allogeneic hematopoietic transplantation was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF [Phase 1]
Phase 1 study evaluating mobilization of autologous peripheral blood stem cells using interleukin-2 and GM-CSF; the trial has completed.
-
CLINICAL_TRIALS research · 2018-04-25Clinical Trial Update: Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research
This clinical trial update describes a protocol to collect blood and bone marrow samples for multiple myeloma research; the study status is …
-
CLINICAL_TRIALS withdrawal · 2018-04-10Clinical Trial Update: Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma [Phase 3]
Phase 3 trial evaluating continuous lenalidomide therapy versus observation after induction without lenalidomide, pomalidomide or thalidomid…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM) [Phase 2]
Phase II, single-center study evaluating a combination of panobinostat, lenalidomide, and dexamethasone in multiple myeloma; results were po…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: To Compare Conservative Management Vs. Balloon Kyphoplasty in the Treatment of VCFs in Patients With Multiple Myeloma [NA]
A clinical trial comparing conservative management to balloon kyphoplasty for vertebral compression fractures in patients with multiple myel…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
This completed clinical trial update evaluates the prognostic potential of cell surface markers and Pim kinase expression in multiple myelom…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Vinorelbine and Gemcitabine in Myeloma [Phase 2]
A Phase 2 clinical trial evaluating vinorelbine and gemcitabine in patients with multiple myeloma (and amyloidosis) has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant [Phase 1]
A Phase 1 trial from Massachusetts General Hospital evaluating recipient leukocyte infusions to prevent donor graft rejection after nonmyelo…
-
CLINICAL_TRIALS other · 2018-03-29Clinical Trial Update: Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) [Phase 1]
This document describes a Phase 1 clinical trial of Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) with Daratumumab for multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma [Phase 2]
Phase 2 study evaluating daratumumab monotherapy and its effects on bone parameters in patients with relapsed or refractory multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan [Phase 2]
Phase II study of lenalidomide/dexamethasone with or without elotuzumab in newly diagnosed multiple myeloma patients in Japan completed with…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
The PENELOPE observational study, which examined prophylaxis and treatment of arterial and venous thromboembolism in patients with hematolog…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating lenalidomide, dexamethasone, and clarithromycin in patients who have undergone stem cell transplant for mu…
-
FDA label_change · 2018-03-20FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for POMALYST (pomalidomide) submitted by Celgene Corporation, resulting in a label change.
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 trial of non-myeloablative HLA-mismatched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was termina…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
A Phase 2 study of non-Myeloablative HLA-matched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was terminat…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma [NA]
This document reports the completion of an open-label trial of perifosine in patients with solid tumors or multiple myeloma, including non-s…